CN100362983C - A traditional Chinese medicine preparation for reducing fever in children and its preparation method - Google Patents
A traditional Chinese medicine preparation for reducing fever in children and its preparation method Download PDFInfo
- Publication number
- CN100362983C CN100362983C CNB2005100032713A CN200510003271A CN100362983C CN 100362983 C CN100362983 C CN 100362983C CN B2005100032713 A CNB2005100032713 A CN B2005100032713A CN 200510003271 A CN200510003271 A CN 200510003271A CN 100362983 C CN100362983 C CN 100362983C
- Authority
- CN
- China
- Prior art keywords
- sub
- preparation
- water
- add
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Landscapes
- Medicinal Preparation (AREA)
Abstract
Description
技术领域: Technical field:
本发明涉及一种小儿退热的中药制剂及其制备方法,尤其涉及小儿退口服液及其制备方法。属于药品技术的领域。The invention relates to a traditional Chinese medicine preparation for reducing fever in children and a preparation method thereof, in particular to Xiaoer Tui oral liquid and a preparation method thereof. Belongs to the field of pharmaceutical technology.
技术背景:小儿脏腑娇嫩,肌肤疏薄,卫外不固,复感风热之邪,或寒从热化,故发热恶风;风热之邪上拢并客于肺则头痛咽肿;如热毒蕴结则有痄腮肿胀,高热等症。故小儿感冒一旦出现高热,急需退热,同时也需宣透疏泄,使邪有出路。小儿退热制剂正是基于上述病理研制而成。Technical background: In children, the viscera are delicate, the skin is sparse and thin, and the external defenses are not solid. They may feel the evil of wind-heat again, or the cold turns from heat, so they have fever and aversion to wind; Accumulation of pyretic toxins has symptoms such as mumps swelling and high fever. Therefore, once a child with a cold develops a high fever, it is urgent to reduce the fever, and at the same time it needs to be ventilated to let the evil have a way out. Pediatric antipyretic preparations are developed based on the above-mentioned pathology.
小儿退热制剂如小儿退热口服液和小儿退热颗粒剂,列入《卫生部药品标准·中药成方制剂》第六册,这两种剂型的工艺技术特点是将牡丹皮、柴胡、连翘用水蒸汽蒸馏,收集蒸馏液,药渣与其余药材加水煎煮二次,方中金银花、连翘、淡竹叶清宣透表,解毒散热;柴胡和解退热,清少阳之热,均为清热透表祛邪之要药。黄芩、大青叶、板蓝根清热解毒,消肿利咽;栀子清泻三焦里热,白薇、牡丹皮配栀子清热凉血,清营血之热,以清里热,与前药相配表里双清;重楼、地龙清热定惊,可防小儿高热惊厥,各药合用,发挥清热透表、解毒利咽作用,共奏退热之功,兼以消肿定惊之效。Pediatric antipyretic preparations such as Xiaoer antipyretic oral liquid and Xiaoer antipyretic granules are included in the sixth volume of "Drug Standards of the Ministry of Health Traditional Chinese Medicine Prescriptions". Forsythia is distilled with water steam, the distillate is collected, and the dregs and other medicinal materials are decocted twice. It is the key medicine for clearing away heat and expelling pathogenic factors. Scutellaria baicalensis, Folium Isatidis, Radix Isatidis clears heat and detoxifies, reduces swelling and sore throat; Gardenia clears and relieves internal heat of the triple energizer, Baiwei, Moutan cortex and Gardenia clears heat and cools blood, clears heat in the blood, clears internal heat, and matches with the prodrug. Li Shuangqing; Zhonglou and Dilong clear away heat and calm convulsions, which can prevent febrile convulsions in children. When used together, these medicines can clear away heat and penetrate the surface, detoxify and relieve sore throat.
目前中医和西医退热药物都以发汗为主。但由于西药的副作用问题,对儿童尤为突出。如布洛芬类对胃黏膜有刺激和损伤。阿司匹林还可诱发哮喘,并且在急性发热性疾病,尤其是流感及水痘患儿应用此药时可能引发瑞尼氏综合症。故世界卫生组织对急性呼吸道感染引发的发热患儿主张不用此药。即使是世界卫生组织推荐的副作用较小的对乙酰氨基酚,对小儿血细胞的影响也不可小视,而中医药在这方面却有一定优势。与退热的西药相比,小儿退热口服液副作用较小,退热较温和、持久、稳定。小儿退热口服液疏风解表、解毒利咽的作用既可治标又可治本,体温下降得快又很少反弹,是医生、家长和患儿都可接受的治疗方法。因此,深入开展小儿退热机理的研究,防止西药不良反应,开发新的小儿退热药物的中成药制剂,发挥中医药治疗小儿发热的优势,具有十分重要的现实意义。At present, both traditional Chinese medicine and Western medicine antipyretic drugs are mainly based on sweating. However, due to the side effects of Western medicine, it is particularly prominent for children. For example, ibuprofen can stimulate and damage the gastric mucosa. Aspirin can also induce asthma and may cause Rainey's syndrome when it is used in children with acute febrile illness, especially influenza and chickenpox. Therefore, the World Health Organization advocates not using this drug for children with fever caused by acute respiratory infection. Even acetaminophen, which has less side effects recommended by the World Health Organization, can not be underestimated the impact on children's blood cells, while traditional Chinese medicine has certain advantages in this regard. Compared with the antipyretic western medicine, Xiaoer Antipyretic Oral Liquid has less side effects, and the antipyretic is milder, lasting and stable. Children's Antipyretic Oral Liquid can relieve wind, relieve exterior, detoxify and sore throat. It can treat both the symptoms and the root cause. The body temperature drops quickly and rarely rebounds. It is an acceptable treatment method for doctors, parents and children. Therefore, it is of great practical significance to carry out in-depth research on the mechanism of antipyretic in children, prevent adverse reactions of western medicines, develop new Chinese patent medicine preparations of antipyretic drugs for children, and give full play to the advantages of traditional Chinese medicine in treating fever in children.
现有小儿退热制剂如口服液和颗粒剂,制备工艺中蒸馏工艺参数制定不严密,导致丹皮酚大量损失。这是因为,牡丹皮中的有效成分丹皮酚具有熔点低49.5-50,水溶性差,极易挥发等特性,因此在其与群药同煮的成品中未能检出丹皮酚。而该工艺在生产过程中又不易控制,不利于大生产,贮存期内不稳定,易产生沉降。同时,发热时期的患儿对味觉颇为敏感,尤其对有苦味的药液容易拒服,即使喂服入口,有时也会吐掉,上述这些都是现有技术中仍未克服的难点。因此,有必要改进工艺,提高制剂质量。In the existing antipyretic preparations for children, such as oral liquid and granules, the distillation process parameters in the preparation process are not strictly formulated, resulting in a large loss of paeonol. This is because paeonol, the active ingredient in Moutan cortex, has a low melting point of 49.5-50, poor water solubility, and is extremely volatile. Therefore, paeonol cannot be detected in the finished product cooked with group medicines. And this technology is difficult to control again in the production process, is unfavorable for large-scale production, unstable in storage period, easily produces settlement. At the same time, children in the febrile period are quite sensitive to the sense of taste, especially they tend to refuse to take bitter medicinal liquids. Even if they are fed, they sometimes spit them out. These are the difficulties that have not been overcome in the prior art. Therefore, it is necessary to improve the process and improve the quality of the preparation.
发明内容: Invention content:
本发明提供一种小儿退热的中药制剂。The invention provides a traditional Chinese medicine preparation for reducing fever in children.
本发明的小儿退热的中药制剂由以下重量配比的中药原料制成:大青叶50~450份、板蓝根30~270份、金银花30~270份、连翘30~270份、栀子30~270份、牡丹皮30~270份、黄芩30~270份、淡竹叶20~180份、地龙20~180份、重楼15~135份、柴胡30~270份、白薇20~180份。The antipyretic traditional Chinese medicine preparation for children of the present invention is made of the following traditional Chinese medicine raw materials in weight ratio: 50-450 parts of Folium Isatidis, 30-270 parts of Radix Radix, 30-270 parts of Honeysuckle, 30-270 parts of Forsythia, 30 parts of Gardenia ~270 parts, 30~270 parts of Moutan bark, 30~270 parts of Scutellaria baicalensis, 20~180 parts of light bamboo leaves, 20~180 parts of Dilong, 15~135 parts of Chonglou, 30~270 parts of Bupleurum, 20~180 parts of Baiwei share.
本发明是将上述中药原料经过提取加工,得到药物活性物质,再通过制剂学常规技术,如将药物活性物质与适量药物可接受的辅料混合制备成任何一种可药用的制剂形式。In the present invention, the above-mentioned traditional Chinese medicine raw materials are extracted and processed to obtain pharmaceutical active substances, and then prepared into any pharmaceutically acceptable preparation form by mixing the pharmaceutical active substances with an appropriate amount of pharmaceutically acceptable adjuvants through the conventional technology of pharmacy.
如优选的中药配方是:大青叶150g、板蓝根90g、金银花90g、连翘90g、栀子90g、牡丹皮90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、柴胡90g、白薇60g。For example, the preferred Chinese medicine formula is: Daqingye 150g, Banlangen 90g, honeysuckle 90g, forsythia 90g, gardenia 90g, Moutan bark 90g, scutellaria baicalensis 90g, light bamboo leaves 60g, earthworm 60g, Chonglou 45g, Bupleurum 90g, white Wei 60g.
以上组成中,中药的重量是以生药计算的,该配方组成可制成药物制剂1000剂。所述1000剂指,制成的成品药物制剂,如制成胶囊制剂1000粒,片剂1000片,颗粒剂1000克,口服液1000ml等,作为颗粒剂也可以制成大包装,如100-500袋,具体可以是100袋、125袋、200袋、250袋、500袋等,每袋可作为1-2次服用剂量。In the above composition, the weight of the traditional Chinese medicine is calculated based on the crude drug, and this formula can be made into 1000 doses of pharmaceutical preparations. The 1000 doses refer to the finished pharmaceutical preparations, such as 1000 capsules, 1000 tablets, 1000 grams of granules, 1000 ml of oral liquid, etc., as granules can also be made into large packages, such as 100-500 Bags, specifically 100 bags, 125 bags, 200 bags, 250 bags, 500 bags, etc., each bag can be used as 1-2 doses.
以上组成,可制成50-1000次服用剂量的制剂,如作为贴剂,制成1000片,制成胶囊1000粒,在使用时根据患儿的情况确定用法用量,可每日服1-3次,每次1-20剂,共可服用50-1000次。如作为颗粒剂,制成125袋,每次服用1-2袋,共可服用62.5-125次。The above composition can be made into a preparation of 50-1000 doses. If it is used as a patch, it can be made into 1000 tablets, and it can be made into 1000 capsules. When using it, the usage and dosage can be determined according to the condition of the child. It can be taken 1-3 times a day. Time, each 1-20 doses, can take 50-1000 times altogether. As granules, make 125 bags, take 1-2 bags each time, and take 62.5-125 times in total.
以上组成是按重量作为配比的,在生产时可按照相应比例增大或减少,如大规模生产可以以公斤为单位,或以吨为单位,小规模生产也可以以毫克为单位,重量可以增大或者减小,但各组成之间的生药材重量配比的比例不变。The above components are proportioned by weight, and can be increased or decreased according to the corresponding proportion during production. For example, the unit of kilogram or ton can be used for large-scale production, and the unit of milligram can also be used for small-scale production. Increase or decrease, but the ratio of the raw medicinal material weight ratio among the components remains unchanged.
以上重量配比的比例是经过科学筛选得到的,对于特殊病人,如重症或轻症,肥胖或瘦小的病人,可以相应调整组成的量的配比,增加或减少不超过100%,药效不变。The proportion of the above weight ratio is obtained through scientific screening. For special patients, such as severe or mild, obese or thin patients, the proportion of the composition can be adjusted accordingly, and the increase or decrease does not exceed 100%. Change.
以上组成中的中药原料,尤其是臣药和佐药,也可以被适当的具有相同药性的中药替换,替换后的中药制剂其药物作用不变。The traditional Chinese medicine raw materials in the above composition, especially the ministerial medicine and the adjuvant medicine, can also be replaced by appropriate Chinese medicines with the same medicinal properties, and the medicine effect of the replaced Chinese medicine preparation remains unchanged.
本发明的药物活性物质可以通过以下方法制备:该制备方法构成本发明的关键。The pharmaceutically active substance of the present invention can be prepared by the following method: This preparation method constitutes the key of the present invention.
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,用水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加4-20倍水煎煮2-5次,每次0.5-2小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%以上,静置。取上清液回收乙醇,浓缩至200ml以上,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量,该浓缩液与蒸馏液合在一起,组成本发明的药物活性物质。For the above twelve flavors, crush Moutan Cortex, Bupleurum, and Forsythia medicinal materials until they all pass 45 mesh, but not 30 mesh, add water according to the ratio of medicine powder to water 1/10, distill with water for 2 hours, and collect the distillate; Add 4-20 times the amount of water to decoct the remaining green leaves and other nine flavors for 2-5 times, each time for 0.5-2 hours, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content more than 70%, and let it stand. place. Take the supernatant to recover ethanol, concentrate to more than 200ml, add water and stir evenly, let stand, take the supernatant, filter, the filtrate is concentrated to an appropriate amount, and the concentrated solution and the distillate are combined to form the pharmaceutical active substance of the present invention.
以该药物活性物质为原料加入药物可接受的辅料,按照制剂学常规技术可制成任何一种药物制剂形式。Taking the pharmaceutical active substance as a raw material and adding pharmaceutically acceptable auxiliary materials, it can be prepared into any pharmaceutical preparation form according to the conventional technology of pharmacy.
本发明的中药制剂可以是任何可药用的剂型,这些剂型包括:口服液、膜剂,灌肠剂,贴剂、糖浆剂、颗粒剂、片剂、胶囊剂、丸剂、散剂、膏剂、丹剂、注射剂、栓剂、霜剂、喷雾剂、滴丸剂、缓释制剂、控释制剂,优选的是口服液。The Chinese medicine preparation of the present invention can be any pharmaceutically acceptable dosage form, and these dosage forms include: oral liquid, film, enema, patch, syrup, granule, tablet, capsule, pill, powder, ointment, pill , injections, suppositories, creams, sprays, dropping pills, sustained-release preparations, controlled-release preparations, preferably oral liquids.
本发明的药物制剂,其口服给药的制剂可含有常用的赋形剂,诸如甜味剂、粘合剂、填充剂、稀释剂、压片剂、润滑剂、崩解剂、着色剂、矫味剂和湿润剂,必要时可对片剂进行包衣。The pharmaceutical preparation of the present invention, its preparation for oral administration may contain common excipients, such as sweeteners, binders, fillers, diluents, tableting agents, lubricants, disintegrants, coloring agents, corrective agents, etc. Flavoring and wetting agents, and tablets may be coated if necessary.
口服液体制剂的形式例如可以是水性或油性悬浮液、溶液、乳剂、糖浆剂或酏剂,或者可以是一种在使用前可用水或其它适宜的载体复配的干燥产品。这种液体制剂可含有常规的添加剂,诸如矫味剂,例如果浆、蔗糖、阿斯巴甜、果葡萄浆、果糖、麦芽糖醇,稳定剂,例如羧甲基纤维钠、山梨醇、糖浆、甲基纤维素、明胶、羟乙基纤维素、羧甲基纤维素、硬脂酸铝凝胶或氢化食用脂肪,乳化剂,例如卵磷脂、脱水山梨醇一油酸酯或阿拉伯胶;非水性载体(它们可以包括食用油),例如杏仁油、分馏椰子油、诸如甘油的酯的油性酯、丙二醇或乙醇;防腐剂,例如苯甲酸钠或丙二醇或对羟基苯甲酯或对羟基苯甲酸丙酯或山梨酸,并且如果需要,可含有常规的香味剂或着色剂。Oral liquid preparations may be in the form of, for example, aqueous or oily suspensions, solutions, emulsions, syrups or elixirs, or may be presented as a dry product for reconstitution with water or other suitable vehicle before use. Such liquid preparations may contain conventional additives such as flavoring agents such as fruit pulp, sucrose, aspartame, grape syrup, fructose, maltitol, stabilizers such as sodium carboxymethylcellulose, sorbitol, syrup, Methylcellulose, gelatin, hydroxyethylcellulose, carboxymethylcellulose, aluminum stearate gel, or hydrogenated edible fats, emulsifiers such as lecithin, sorbitan monooleate, or acacia; nonaqueous Carriers (which may include edible oils) such as almond oil, fractionated coconut oil, oily esters such as glycerol, propylene glycol or ethanol; preservatives such as sodium benzoate or propylene glycol or paraben or propylparaben or sorbic acid and, if desired, conventional flavoring or coloring agents.
适用的填充剂包括纤维素、甘露糖醇、乳糖和其它类似的填充剂。适宜的崩解剂包括淀粉、聚乙烯吡咯烷酮和淀粉衍生物,例如羟基乙酸淀粉钠。适宜的润滑剂,例如硬脂酸镁。适宜的药物可接受的湿润剂包括十二烷基硫酸钠。Suitable fillers include cellulose, mannitol, lactose and other similar fillers. Suitable disintegrants include starch, polyvinylpyrrolidone and starch derivatives such as sodium starch glycolate. Suitable lubricants, such as magnesium stearate. Suitable pharmaceutically acceptable wetting agents include sodium lauryl sulfate.
可通过混合,填充,压片等常用的方法制备固体口服组合物。进行反复混合可使活性物质分布在整个使用大量填充剂的那些组合物中。Solid oral compositions can be prepared by common methods such as mixing, filling, and tabletting. Repeated mixing is performed to distribute the active material throughout those compositions where large amounts of fillers are used.
对于注射剂,制备的液体单位剂型含有本发明的活性物质和无菌载体。根据载体和浓度,可以将此化合物悬浮或者溶解。溶液的制备通常是通过将活性物质溶解在一种载体中,在将其装入一种适宜的小瓶或安瓿前过滤消毒,然后密封。辅料例如一种局部麻醉剂、防腐剂和缓冲剂也可以溶解在这种载体中。为了提高其稳定性,可在装入小瓶以后将这种组合物冰冻,并在真空下将水除去。For injections, liquid unit dosage forms are prepared containing the active material of the invention in association with a sterile carrier. Depending on the carrier and concentration, the compound can be suspended or dissolved. Solutions are usually prepared by dissolving the active substance in a carrier and filter sterilizing before filling into a suitable vial or ampoule, which is then sealed. Adjuvants such as a local anesthetic, preservatives and buffering agents can also be dissolved in the vehicle. To increase its stability, the composition can be frozen after filling vials and the water removed under vacuum.
本发明的药物制剂,在制备成药剂时可选择性的加入适合的药物可接受的载体,所述药物可接受的载体优选的选自:甘露醇、山梨醇、焦亚硫酸钠、亚硫酸氢钠、硫代硫酸钠、盐酸半胱氨酸、巯基乙酸、蛋氨酸、维生素C、EDTA二钠、EDTA钙钠,一价碱金属的碳酸盐、醋酸盐、磷酸盐或其水溶液、盐酸、醋酸、硫酸、磷酸、氨基酸、氯化钠、氯化钾、乳酸钠、木糖醇、麦芽糖、葡萄糖、果糖、右旋糖苷、甘氨酸、淀粉、蔗糖、乳糖、甘露糖醇、硅衍生物、纤维素及其衍生物、藻酸盐、明胶、聚乙烯吡咯烷酮、甘油、土温80、琼脂、碳酸钙、碳酸氢钙、表面活性剂、聚乙二醇、环糊精、β-环糊精、磷脂类材料、高岭土、滑石粉、微粉硅胶、碳酸镁、硬脂酸钙、硬脂酸镁等。The pharmaceutical preparation of the present invention can optionally add a suitable pharmaceutically acceptable carrier when it is prepared into a medicament, and the pharmaceutically acceptable carrier is preferably selected from: mannitol, sorbitol, sodium metabisulfite, sodium bisulfite, Sodium thiosulfate, cysteine hydrochloride, thioglycolic acid, methionine, vitamin C, disodium EDTA, calcium sodium EDTA, monovalent alkali metal carbonates, acetates, phosphates or their aqueous solutions, hydrochloric acid, acetic acid, Sulfuric acid, phosphoric acid, amino acid, sodium chloride, potassium chloride, sodium lactate, xylitol, maltose, glucose, fructose, dextran, glycine, starch, sucrose, lactose, mannitol, silicon derivatives, cellulose and its Derivatives, alginate, gelatin, polyvinylpyrrolidone, glycerin, Twain 80, agar, calcium carbonate, calcium bicarbonate, surfactant, polyethylene glycol, cyclodextrin, β-cyclodextrin, phospholipid materials , kaolin, talc, micropowder silica gel, magnesium carbonate, calcium stearate, magnesium stearate, etc.
根据本发明,最优选的制剂形式是口服液,其基本制备方法包括,将上述药物活性物质与矫味剂,稳定剂,防腐剂混合,如:上述药物活性物质与用蔗糖400g以上制成的糖浆混合,再加入稳定剂,防腐剂适量,用水调整总量至规定量,搅匀,滤过,灌装,灭菌,即得。According to the present invention, the most preferred preparation form is an oral liquid, and its basic preparation method includes mixing the above-mentioned pharmaceutical active substance with a flavoring agent, a stabilizer, and a preservative, such as: the above-mentioned pharmaceutical active substance is mixed with more than 400 g of sucrose. Mix the syrup, then add stabilizer and appropriate amount of preservatives, adjust the total amount with water to the specified amount, stir well, filter, fill, and sterilize to get ready.
具体如:以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,用水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加10倍水煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至约200ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取蔗糖400g制成糖浆,与上述药液及蒸馏液合并,再加入适量稳定剂、防腐剂,调整总量至1000ml,搅匀,滤过,灌装灭菌,即得。Specifically, for the above twelve flavors, crush the cortex moutan, bupleurum, and forsythia medicinal materials until they all pass 45 mesh, but not 30 mesh, add water at a ratio of 1/10 of the powder to water, distill with water for 2 hours, and collect the distillate; Add 10 times the amount of water to decoct the dregs and the rest of the green leaves and other nine flavors for two times, 1 hour each time, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to about 200ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another 400g of sucrose to make a syrup, combine with the above liquid medicine and distillate, then add appropriate amount of stabilizer and preservative, adjust the total amount to 1000ml, stir well, filter, fill and sterilize to get ready.
本发明口服液最佳制备方法为:大青叶150g、板蓝根90g、金银花90g、连翘90g、栀子90g、牡丹皮90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、柴胡90g、白薇60g,以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即2700ml,用水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加7350ml水煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至200ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取蔗糖400g制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠8g、苯甲酸钠0.1%,调整总量至1000ml,搅匀,滤过,灌装,灭菌,即得。The best preparation method of the oral liquid of the present invention is: 150g of Daqingye, 90g of Radix Isatidis, 90g of Honeysuckle, 90g of Forsythia, 90g of Gardenia, 90g of Moutan Cortex, 90g of Scutellaria, 60g of Bamboo Leaf, 60g of Dilong, 45g of Chonglou, Bupleurum 90g, Baiwei 60g, the above twelve flavors, crush the medicinal materials of Moutan Cortex, Bupleurum, and Forsythia until they all pass 45 mesh, but not 30 mesh, add water according to the ratio of medicine powder to water 1/10, that is, 2700ml, and steam distill 2h, collect the distillate; decoct the dregs and the rest of the green leaves and other nine flavors with 7350ml of water twice, 1 hour each time, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, stand still. Take the supernatant to recover ethanol, concentrate to 200ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another 400g of sucrose to make syrup, combine with the above liquid medicine and distillate, then add 8g of sodium carboxymethylcellulose and 0.1% of sodium benzoate, adjust the total amount to 1000ml, stir well, filter, fill, and sterilize, namely have to.
所说的水蒸馏工艺特征在于将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,用水蒸汽蒸馏2h;所说的水煎煮工艺特征在于最终含醇量70%,蔗糖,羧甲基纤维钠和药液浓缩量之比为50∶25∶1,最佳为最终含醇量70%,蔗糖400g,羧甲基纤维钠8g,药液浓缩量200ml。Said water distillation process is characterized in that cortex Moutan, Radix Bupleurum and Forsythia medicinal materials are pulverized until they all pass through 45 meshes, but cannot pass through 30 meshes, add water according to the ratio of medicine powder to water at 1/10, and steam distill for 2 hours; said water The decoction process is characterized in that the final alcohol content is 70%, the ratio of sucrose, sodium carboxymethyl cellulose and the concentration of the medicinal solution is 50:25:1, the best is the final alcohol content of 70%, sucrose 400g, carboxymethyl fiber Sodium 8g, liquid concentration 200ml.
本发明优选的口服液的制剂,其优选的配方组成如下:The preparation of the preferred oral liquid of the present invention, its preferred formula is composed as follows:
本发明的药物活性物质:大青叶150g、板蓝根90g、金银花90g、连翘90g、栀子90g、牡丹皮90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、柴胡90g、白薇60g。Pharmaceutical active substance of the present invention: Folium Isatidis 150g, Radix Radix 90g, Honeysuckle 90g, Forsythia 90g, Gardenia 90g, Cortex Moutan 90g, Scutellaria baicalensis 90g, Bamboo leaves 60g, Earthworm 60g, Chonglou 45g, Bupleurum 90g, Wei 60g.
矫味剂:蔗糖、阿斯巴甜、果葡萄浆、果糖和麦芽糖醇。Flavorings: Sucrose, Aspartame, Grape Syrup, Fructose and Maltitol.
稳定剂:羧甲基纤维钠。Stabilizer: sodium carboxymethylcellulose.
防腐剂:对羟基苯甲酸乙酯、对羟基苯甲酸甲酯、苯甲酸钠、苯甲酸和山梨酸。Preservatives: Ethylparaben, Methylparaben, Sodium Benzoate, Benzoic Acid, and Sorbic Acid.
最优选的配方组成如下:The most preferred formula consists of the following:
本发明的药物活性物质:大青叶150g、板蓝根90g、金银花90g、连翘90g、栀子90g、牡丹皮90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、柴胡90g、白薇60g。Pharmaceutical active substance of the present invention: Folium Isatidis 150g, Radix Radix 90g, Honeysuckle 90g, Forsythia 90g, Gardenia 90g, Cortex Moutan 90g, Scutellaria baicalensis 90g, Bamboo leaves 60g, Earthworm 60g, Chonglou 45g, Bupleurum 90g, Wei 60g.
矫味剂:阿斯巴甜Flavoring agent: Aspartame
稳定剂:羧甲基纤维钠Stabilizer: sodium carboxymethylcellulose
防腐剂:苯甲酸钠Preservative: Sodium Benzoate
以上最优选的配方组成是经过筛选得到的,使口感大大的改善。The above most preferred formula composition is obtained through screening, so that the mouthfeel is greatly improved.
本发明小儿退热口服液与中药成方制剂所载现有技术相比,其水蒸馏工艺参数确定,保证了丹皮酚有效成分的提出,避免原工艺造成丹皮酚大量损失,容易检出丹皮酚,提高了药效,稳定了质量,口感好,生物利用度高;同时操作可行,容易控制,便于大生产。Compared with the prior art contained in traditional Chinese medicine preparations, the children's antipyretic oral liquid of the present invention has definite parameters of the water distillation process, which ensures the extraction of the active ingredient of paeonol, avoids a large loss of paeonol caused by the original process, and is easy to detect Paeonol has improved drug efficacy, stabilized quality, good taste, and high bioavailability; at the same time, it is feasible to operate, easy to control, and convenient for mass production.
上述优点通过以下工艺实验来作进一步证实:The above advantages are further confirmed by the following process experiments:
1本发明提取挥发油(包括丹皮酚)的最佳工艺实验:1 The best process experiment of the present invention extracting volatile oil (comprising paeonol):
1.1本发明采用共水蒸馏法进行提取,取牡丹皮、柴胡、连翘的粉碎样品30g,设置3个蒸馏参数:A蒸馏时间;B蒸馏时粉碎样品与加水量的比率;C药材粉碎程度,以此作为考察的3个因素。1.1 The present invention adopts co-water distillation method to extract, take 30g of pulverized samples of Cortex Moutan, Bupleurum and Forsythia, set 3 distillation parameters: A distillation time; B the ratio of pulverized samples to the amount of water added during distillation; C medicinal material pulverization degree , as the three factors investigated.
1.1.1每个参数选择3组值,分别为:A1蒸馏时间2h;A2蒸馏时间小于2h;A3蒸馏时间大于2h;B1药粉与水比率1/20,即加水900ml;B2药粉与水比率1/15,即加水675ml;B3药粉与水比率1/10,即加水450ml;C1药材粉碎至全部通过30目;C2药材粉碎至全部通过45目,但不能过30目;C3药材粉碎至全部通过60目,但不能过45目。全部参数互相组合为9个处理,组合符合拉丁方设计,详见表1.1.1.1 Choose 3 sets of values for each parameter, which are: A 1 Distillation time 2h; A 2 Distillation time less than 2h; A 3 Distillation time greater than 2h; B 1 The ratio of powder to water is 1/20, that is, add water 900ml; B 2 The ratio of medicine powder to water is 1/15, that is, add 675ml of water; the ratio of B3 medicine powder to water is 1/10, that is , add 450ml of water ; Mesh; C 3 medicinal materials are crushed until they all pass 60 mesh, but not 45 mesh. All parameters were combined into 9 treatments, and the combinations conformed to the Latin square design, see Table 1 for details.
1.2挥发油中所含成分分析:1.2 Analysis of the components contained in the volatile oil:
1.2.1 GC条件:色谱柱为DB5石英毛细管柱,30m×0.25mm×0.25μm;载气为高纯氦(99.999%);柱流量1ml Pmin,不分流;柱前压:100kPa;进样口温度220℃;进样量1μl.程序升温:柱温40℃保持1min,以10℃Pmin升高到200℃保持3min.DSQ条件:电离方式EI,电子能量70eV;接口温度210℃,离子源温度200℃;流量扫描范围50~350;溶剂延迟4.0min;发射电流100μA.1.2.1 GC conditions: the chromatographic column is a DB5 quartz capillary column, 30m×0.25mm×0.25μm; the carrier gas is high-purity helium (99.999%); the column flow rate is 1ml Pmin, splitless; the front pressure of the column: 100kPa; the injection port Temperature 220°C; injection volume 1μl. Temperature program: column temperature 40°C for 1min, 10°C Pmin to 200°C for 3min. DSQ conditions: ionization mode EI, electron energy 70eV; interface temperature 210°C, ion source temperature 200℃; flow scanning range 50~350; solvent delay 4.0min; emission current 100μA.
表1 蒸馏挥发油应用蒸馏参数的变化方阵(拉丁方设计)Table 1 Variation matrix of distillation parameters for distillation of essential oils (Latin square design)
2结果与分析2 Results and Analysis
2.1不同蒸馏参数对挥发油产率的影响(见表2)2.1 The influence of different distillation parameters on the yield of volatile oil (see Table 2)
表2 不同蒸馏参数组合后对挥发油的产率Table 2 The yield of volatile oil after different distillation parameter combinations
从表2中可以看出:9种不同参数组合的蒸馏条件显著地影响了挥发油的产出率,其中,产出率最高的组合为组合A2B2C3,产油率高达3.54%;产出率最低的组合为组合A1B3C2,产油率为0.367%,两者相差6.6倍。It can be seen from Table 2 that the distillation conditions of 9 different parameter combinations significantly affect the yield of volatile oil, and the combination with the highest yield is the combination A 2 B 2 C 3 , with an oil yield as high as 3.54%; The combination with the lowest yield is A 1 B 3 C 2 , with an oil yield of 0.367%, a difference of 6.6 times.
为比较3个蒸馏条件对挥发油产率影响的大小,本实验进行了方差分析(表3),从表3可看出:本实验中,对挥发油产率影响最大的因素是蒸馏时间,其次是粉碎药粉与所加水的比率,对其影响最小的是药材粉碎程度。In order to compare the size of the influence of 3 distillation conditions on the yield of volatile oil, this experiment has carried out analysis of variance (table 3), as can be seen from table 3: in this experiment, the factor that has the greatest impact on the yield of volatile oil is distillation time, followed by The ratio of pulverized medicinal powder to added water has the least influence on the pulverization degree of medicinal materials.
表3 挥发油产量的方差分析Table 3 Analysis of variance of volatile oil production
2.2不同蒸馏参数对挥发油中所含成分丹皮酚的影响见表42.2 The influence of different distillation parameters on paeonol contained in the volatile oil is shown in Table 4
表4 用不同参数组合进行水蒸馏得到的挥发油主要成分百分率变化Table 4 Changes in the percentage of main components of volatile oil obtained by water distillation with different parameter combinations
通过对不同蒸馏参数所蒸馏出的挥发油进行GC-DSQ分析,得出6种主要成分的相对百分含量(表4)。从实验结果可以看出:在蒸馏时间为2小时的组合中丹皮酚的相对含量较高,其中组合3(A1B3C2)的丹皮酚的含量达93.11%,表明蒸馏时间直接影响丹皮酚的蒸出率.除丹皮酚以外,其他成分较高的相对百分含量出现在其他的蒸馏时间组合中。Through the GC-DSQ analysis of the volatile oil distilled by different distillation parameters, the relative percentages of the six main components were obtained (Table 4). From the experimental results, it can be seen that the relative content of paeonol in the combination with a distillation time of 2 hours is relatively high, and the content of paeonol in combination 3 (A 1 B 3 C 2 ) reaches 93.11%, indicating that the distillation time is directly Affect the distillation rate of paeonol. Except for paeonol, the relative percentages of other components appear in other distillation time combinations.
3结论3 Conclusion
现有技术中,提取挥发油虽然有很多种方法,但经常使用的主要是蒸馏法.这就要求我们认真地选择蒸馏参数值,确定最佳参数组合,以提高蒸馏产量和油的质量.从本发明实验结果可以看出:蒸馏参数对挥发油的产量和成分的影响较大,其中蒸馏时间对挥发油产量具有显著的影响,蒸馏时间为2h,油的产量越高。此外,就丹皮酚来说,在蒸馏时间为2小时的组合中丹皮酚的相对含量最高。因此本发明中,设定的最佳蒸馏条件为蒸馏时间2h,加水450ml,药材粉碎至全部通过45目,但不能过30目。In the prior art, although there are many methods for extracting volatile oil, distillation is the most commonly used method. This requires us to carefully select distillation parameter values and determine the best combination of parameters to improve distillation yield and oil quality. From this From the experimental results of the invention, it can be seen that the distillation parameters have a greater impact on the yield and composition of the volatile oil, and the distillation time has a significant impact on the yield of the volatile oil. The higher the yield of the oil is, the more the distillation time is 2 hours. Furthermore, in the case of paeonol, the relative content of paeonol was highest in the combination with a distillation time of 2 hours. Therefore in the present invention, the optimum distillation condition of setting is distillation time 2h, adds water 450ml, and medical material is pulverized to all through 45 orders, but can not pass 30 orders.
为了稳定质量,使口感良好,我们所所加入的辅料进行了一系列筛选实验:In order to stabilize the quality and make the taste good, we have conducted a series of screening experiments on the excipients we added:
实验一:通过正交实验对药液量与辅料最佳配比进行选择,考察制剂的稳定性:Experiment 1: Select the optimal ratio of drug solution volume and excipients through orthogonal experiments, and investigate the stability of the preparation:
1实验材料1 Experimental materials
1.1按本发明制法制得以牡丹皮、柴胡、连翘水蒸汽蒸馏蒸馏后的药渣混其余青叶等九味煎煮的水煎浓缩液,醇沉,蒸馏液,与蔗糖、羧甲基纤维钠混匀,即得。1.1 According to the method of the present invention, the decoction concentrated solution obtained by mixing the medicinal dregs after steam distillation and distillation of Cortex Moutan, Bupleurum, and Forsythia with the other nine flavors such as green leaves, alcohol precipitation, distillate, and sucrose, carboxymethyl Fiber sodium mixed, that is.
1.2蔗糖、羧甲基纤维钠均为药用。1.2 Both sucrose and sodium carboxymethylcellulose are used for medicine.
2实验方法与结果2 Experimental methods and results
选用L9(34)正交设计表安排实验。Choose L 9 (3 4 ) orthogonal design table to arrange experiments.
表1因素水平Table 1 Factor levels
表2 L9(34)正交实验结果Table 2 Orthogonal experiment results of L 9 (3 4 )
结论:由表中数据可知,工艺A1B3C2D2和A1B3C2D2制得的稳定性良好,准存期内,混匀均匀,但A1B3C2D2工艺蔗糖用量大,服用量大,故选A1B3C2D2。即醇沉度70%,蔗糖,羧甲基纤维钠和药液浓缩量之比为50∶25∶1;最佳为醇沉度70%,蔗糖400g,羧甲基纤维钠8g,药液浓缩量200ml。用70%乙醇醇沉,依此工艺配比制备各批口服液,室温观察1年,稳定好;羧甲基纤维钠为稳定剂,30min后几乎无沉降药液均匀,外观好。Conclusion: From the data in the table, it can be seen that the stability of the process A 1 B 3 C 2 D 2 and A 1 B 3 C 2 D 2 is good, and the quasi-storage period is evenly mixed, but A 1 B 3 C 2 D 2 The amount of sucrose used in the process is large, and the dosage is large, so choose A 1 B 3 C 2 D 2 . That is, the alcohol precipitation is 70%, the ratio of sucrose, sodium carboxymethyl cellulose and the concentration of the medicinal solution is 50:25:1; the best is the alcohol precipitation of 70%, 400g of sucrose, 8g of sodium carboxymethylcellulose, and concentrated medicinal solution Volume 200ml. Precipitate with 70% ethanol, prepare each batch of oral liquid according to the process ratio, observe at room temperature for 1 year, and the stability is good; sodium carboxymethylcellulose is used as a stabilizer, after 30 minutes, there is almost no sedimentation, the liquid is uniform, and the appearance is good.
实验二:对矫味剂的选择,以此考察制剂的口感。Experiment 2: The choice of flavoring agent to examine the mouthfeel of the preparation.
实验如下:按本发明实验一中蔗糖用量,我们分别用阿斯巴甜、果葡萄浆、果糖、麦芽糖醇替换蔗糖,分成5组,按照本发明技术制备成口服液,依次比较其口感,结果如下:The experiment is as follows: according to the amount of sucrose in Experiment 1 of the present invention, we replaced sucrose with aspartame, fruit grape pulp, fructose, and maltitol respectively, divided into 5 groups, prepared oral liquid according to the technology of the present invention, and compared its mouthfeel in turn. as follows:
表1矫味剂对本发明的影响考察The impact of table 1 flavoring agent on the present invention is investigated
以上考察表明:加入矫味剂后,能够增强患儿服药的顺应性,其效果依次排列为阿斯巴甜>果葡萄浆>果糖>麦芽糖醇>蔗糖。The above investigations showed that the addition of flavoring agents can enhance children's medication compliance, and the order of effect is aspartame > fruit grape pulp > fructose > maltitol > sucrose.
实验三:对防腐剂的选择:Experiment 3: Choice of preservatives:
由于本发明膏滋中含有大量的糖份,在储存过程中容易滋生微生物,发生霉变,从而影响药物的质量。所以本发明膏滋中可加入适量防腐剂,但是如果防腐剂使用不当,也会影响药剂的质量。以下是对防腐剂的选择实验结果:Because the ointment of the present invention contains a large amount of sugar, it is easy to breed microorganisms and mildew during storage, thereby affecting the quality of the medicine. Therefore, an appropriate amount of preservative can be added to the ointment of the present invention, but if the preservative is used improperly, it will also affect the quality of the medicament. The following are the experimental results for the selection of preservatives:
注:-表示无变化;+表示有少量霉菌;++表示有霉菌;0表示发酵酸败。Note: - indicates no change; + indicates a small amount of mold; ++ indicates mold; 0 indicates fermentation rancidity.
根据表中实验结果比较,我们选择苯甲酸钠作为防腐剂。According to the comparison of experimental results in the table, we choose sodium benzoate as preservative.
由于苯甲酸钠作为防腐剂时用量越大,对药品质量没有明显的变化,但是会对人体造成损害,在本制剂中苯甲酸钠的用量以不超过0.2%为宜,其最小使用量的选择实验结果为:Because when sodium benzoate is used as a preservative, the amount is bigger, there is no obvious change to the quality of medicines, but it will cause damage to the human body. In this preparation, the amount of sodium benzoate is preferably no more than 0.2%. for:
根据表中实验结果,本制剂中苯甲酸钠的有效使用量为0.10%-0.20%。According to experimental result in the table, the effective usage amount of sodium benzoate is 0.10%-0.20% in this preparation.
有益效果:主要药效学试验结果表明:本发明小儿退热口服液具有明显的退热、抗炎作用,这些药理作用,通过以下试验例得到证实,而试验结果又为临床推广应用提供了依据。下述试验例用于进一步说明本发明。Beneficial effects: the main pharmacodynamic test results show that the children's antipyretic oral liquid of the present invention has obvious antipyretic and anti-inflammatory effects, and these pharmacological effects are confirmed by the following test examples, and the test results provide a basis for clinical application . The following test examples are used to further illustrate the present invention.
试验例1 本发明小儿退热口服液对家兔感染性发热的退热效果。Test Example 1 The antipyretic effect of Xiaoer antipyretic oral liquid of the present invention on infectious fever in rabbits.
1 材料与方法1 Materials and methods
1.1动物:新西兰大耳白兔56只(贵阳医学院动物实验室提供),体重2.0±0.2kg,雌雄各半。1.1 Animals: 56 New Zealand big-eared white rabbits (provided by the Animal Laboratory of Guiyang Medical College), weighing 2.0±0.2kg, half male and half male.
1.2药物:1.2 Drugs:
按照《卫生部药品标准·中药成方制剂》第六册所载工艺制备而成的小儿退热颗粒,以下简称药物A;Xiaoer Tuire Granules prepared in accordance with the process contained in the sixth volume of "Drug Standards of the Ministry of Health Chinese Medicine Prescriptions", hereinafter referred to as drug A;
按本发明工艺制成的小儿退热口服液,以下简称药物B。The antipyretic oral liquid for children made by the process of the present invention is hereinafter referred to as medicine B.
1.3 方法:取新西兰大耳白兔56只,雌雄兼用,随机分为7组,每组8只。禁食不禁水12h。在20±1℃室温下,固定家兔,待安静后,用PD-U型数字温度计(德国产)连续测2次肛温,实验前均经标准温度计(重庆医用仪表厂产)校正。每次隔30min,求平均值作为正常体温。正常体温确定后,各组动物按1.0mlPkg静注伤寒副伤寒甲乙三联菌液。60min时,按上述方法测定致热后体温变化。然后,一组灌服常水做为阴性对照组,三组分别灌服不同剂量的小儿退热颗粒剂,余三组分别灌服不同剂量的小儿退热口服液。给药后依次测定30、60、120、180、240和300min时的体温,并将各组动物的正常体温与该组动物致热后给药前的体温进行配对t检验,求其正常体温与致热后体温的统计学意义。同时将给药动物组体温与对照组进行组间t检验,分别计算并比较致热后的体温变化。试验结果如下表:1.3 Method: Take 56 New Zealand big-eared white rabbits, both male and female, and divide them into 7 groups randomly, 8 rabbits in each group. Fasting without water for 12h. The rabbits were fixed at a room temperature of 20±1°C, and after being quiet, the rectal temperature was measured twice consecutively with a PD-U digital thermometer (made in Germany), which was calibrated by a standard thermometer (made in Chongqing Medical Instrument Factory) before the experiment. Every 30 minutes, the average value was taken as the normal body temperature. After the normal body temperature was determined, the animals in each group were intravenously injected with typhoid and paratyphoid triple A and B bacteria liquid at 1.0mlPkg. At 60 minutes, the temperature change after heating was measured according to the above method. Then, one group was fed with normal water as a negative control group, three groups were fed with different doses of Xiaoer Tuire Granules, and the remaining three groups were fed with different doses of Xiaoer Tuire Oral Liquid. Measure the body temperature at 30, 60, 120, 180, 240, and 300 minutes after the administration, and carry out paired t-test between the normal body temperature of each group of animals and the body temperature before the administration after the animals in this group were given heat. Statistical significance of post-pyrogenic body temperature. At the same time, the body temperature of the treated animal group and the control group were subjected to inter-group t-test, and the body temperature changes after heating were calculated and compared respectively. The test results are as follows:
附表 小儿退热口服液对致热后家兔的影响 Attached Table: Effect of Xiaoer Tuire Oral Liquid on Febrile Rabbits
#P<0.01给药前致热后1h与正常体温比较。#P<0.01Compared with normal body temperature 1h after heating before administration.
*P<0.01给药后1h与给药前致热后体温比较。*P<0.01Compared with body temperature after heating 1h after administration and before administration.
△P<0.01各给药组给药后1h与对照组相应点的体温比较。△P<0.01Compared with the body temperature of the control group at 1h after administration in each administration group.
2结果2 results
家兔被静注三联菌液1h后,产生致热效应,体温明显增高。与致热前比较,差异有显著性(P<0.01)。致热后的家兔分别灌喂小儿退热颗粒剂(药物A)和小儿退热口服液(药物B)后,药物B组体温明显降低,与致热后给药前体温比较,差异有非常显著性(P<0.01);而药物A体温降低不明显。各给药组给药后1h体温与对照组相应时间的体温比较,药物B组差异有非常显著性(P<0.01),药物A组差异不显著性,见附表。One hour after the rabbit was intravenously injected with the triple bacteria solution, a pyrogenic effect was produced, and the body temperature increased significantly. Compared with before heating, the difference was significant (P<0.01). After the fever-induced rabbits were fed with Xiaoer Tuire Granules (Drug A) and Xiaoer Tuire Oral Liquid (Drug B), the body temperature of the Drug B group decreased significantly. Significant (P<0.01); while drug A did not lower body temperature significantly. Comparing the body temperature of each administration group 1h after administration with the body temperature of the control group at the corresponding time, the difference in the drug group B is very significant (P<0.01), and the difference in the drug group A is not significant, see the attached table.
结果表明,本发明小儿退热口服液能降低家兔的感染性发热。The results show that the Xiao'er antipyretic oral liquid of the present invention can reduce infectious fever in rabbits.
试验例2本发明小儿退热口服液抗炎效果Test example 2 Anti-inflammatory effect of children's antipyretic oral liquid of the present invention
1材料与方法1 Materials and methods
1.1动物:昆明种雄性小鼠40只(贵阳医学院动物实验室提供),体重27±0.5g。1.1 Animals: 40 Kunming male mice (provided by the Animal Laboratory of Guiyang Medical College), weighing 27±0.5g.
1.2药物:1.2 Drugs:
药物A:阿司匹林(市售)Drug A: Aspirin (commercially available)
药物B:按本发明工艺制成的小儿退热口服液;Medicine B: the antipyretic oral liquid for children made by the process of the present invention;
空白对照组。Blank control group.
1.3方法:取雄性小鼠40只,随机分为小儿退热口服液大剂量组40ml·kg-1,小儿退热口服液小剂量组10ml·kg-1,小儿退热口服液小剂量组30ml·kg-1及空白对照组,每组10只,均为一次性灌胃给药(40ml·kg-1),对照组给等量蒸馏水。给药1.5h后,每鼠左耳涂二甲苯30ul致炎,右耳作为对照,致炎30min后将小鼠处死,用直径9mm打孔器分别在同一部位打下耳片,称重,以左耳重减右耳重作为肿胀度。给药组与对照组进行比较,计算肿胀率。见表1。1.3 Method: 40 male mice were randomly divided into Xiaoer Tuire Oral Liquid high-dose group 40ml·kg -1 , Xiaoer Tuire Oral Liquid small-dose group 10ml·kg -1 , Xiaoer Tuire Oral Liquid low-dose group 30ml ·kg -1 and the blank control group, 10 rats in each group, were administered intragastrically (40ml·kg -1 ) once, and the control group was given the same amount of distilled water. After 1.5 hours of administration, the left ear of each mouse was smeared with 30ul of xylene to cause inflammation, and the right ear was used as a control. After 30 minutes of inflammation, the mice were killed, and ear pieces were respectively punched at the same position with a 9mm diameter puncher, weighed, and the left ear was used as a control. The ear weight minus the right ear weight was used as the degree of swelling. The administration group was compared with the control group, and the swelling rate was calculated. See Table 1.
表1本发明口服液对二甲苯所致小数耳廓肿胀的影响The impact of table 1 oral liquid of the present invention on the swelling of the small auricle due to xylene
结果表明,本发明口服液对二甲苯所致小数耳廓肿胀有明显的抑制作用。The results show that the oral liquid of the present invention has obvious inhibitory effect on the swelling of the small auricle caused by xylene.
具体实施方式 Detailed ways
下面结合事实例对本发明作进一步的说明,下列各事实例仅用于说明本发明,对本发明并无限制。The present invention will be further described below in conjunction with the examples, and the following examples are only used to illustrate the present invention, and the present invention is not limited.
实施例1Example 1
大青叶150g、板蓝根90g、金银花90g、栀子90g、牡丹皮90g、柴胡90g、连翘90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、白薇60g、蔗糖400g、羧甲基纤维钠8g及苯甲酸钠1gDaqingye 150g, Banlangen 90g, Honeysuckle 90g, Gardenia 90g, Moutan bark 90g, Bupleurum 90g, Forsythia 90g, Scutellaria baicalensis 90g, Bamboo leaf 60g, Dilong 60g, Chonglou 45g, Baiwei 60g, sucrose 400g, carboxylate Sodium methylcellulose 8g and sodium benzoate 1g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即加水2700ml,用水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水7350ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至200ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取蔗糖400g制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠、苯甲酸钠,调整总量至1000ml,搅匀滤过,灌装,灭菌,即得。For the above twelve flavors, crush Moutan Cortex, Bupleurum and Forsythia medicinal materials until they all pass 45 mesh, but not 30 mesh, add water according to the ratio of medicine powder to water 1/10, that is, add 2700ml of water, steam distill for 2 hours, and collect the distillate Add 7350ml of water to decoct the dregs of the medicinal herbs and other nine flavors such as green leaves for two times, each time for 1 hour, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 200ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another 400g of sucrose to make syrup, combine with the above liquid medicine and distillate, then add sodium carboxymethylcellulose and sodium benzoate, adjust the total amount to 1000ml, stir well, filter, fill, and sterilize to get ready.
实施例2Example 2
大青叶150g、板蓝根90g、金银花90g、栀子90g、牡丹皮90g、柴胡90g、连翘90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、白薇60g、阿斯巴甜400g、羧甲基纤维钠8g及苯甲酸钠1gDaqingye 150g, Banlangen 90g, Honeysuckle 90g, Gardenia 90g, Moutan bark 90g, Bupleurum 90g, Forsythia 90g, Scutellaria baicalensis 90g, Bamboo leaf 60g, Dilong 60g, Chonglou 45g, Baiwei 60g, Aspartame 400g, sodium carboxymethylcellulose 8g and sodium benzoate 1g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即加水2700ml,水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水7350ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至200ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取阿斯巴甜制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠、苯甲酸钠,调整总量至1000ml,搅匀,滤过,灌装,灭菌,即得。For the above twelve flavors, crush Moutan Cortex, Bupleurum, and Forsythia until all of them pass through 45 meshes, but not 30 meshes. Add water according to the ratio of powder to water 1/10, that is, add 2700ml of water, steam distill for 2 hours, and collect the distillate Add 7350ml of water to decoct the dregs of the medicinal herbs and other nine flavors such as green leaves for two times, each time for 1 hour, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 200ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another aspartame to make syrup, combine with the above liquid medicine and distillate, then add sodium carboxymethylcellulose and sodium benzoate, adjust the total amount to 1000ml, stir well, filter, fill, and sterilize to obtain .
实施例3大青叶50g、板蓝根30g、金银花30g、连翘30g、栀子30g、牡丹皮30g、黄芩30g、淡竹叶20g、地龙20g、重楼15g、柴胡30g、白薇20g、果葡萄浆400g、羧甲基纤维钠8g及苯甲酸钠0.34gExample 3 Folium Folium 50g, Radix Isatidis 30g, Honeysuckle 30g, Forsythia 30g, Gardenia 30g, Moutan bark 30g, Scutellaria baicalensis 30g, Bamboo leaves 20g, Dilong 20g, Chonglou 15g, Bupleurum 30g, Baiwei 20g, fruit Grape pulp 400g, sodium carboxymethylcellulose 8g and sodium benzoate 0.34g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即加水900ml,水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水2450ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至200ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取果葡萄浆制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠、苯甲酸钠,调总量至1000ml,搅匀滤过,灌装,灭菌,即得。For the above twelve flavors, crush Moutan Cortex, Bupleurum, and Forsythia until they pass through 45 meshes, but not 30 meshes, add water according to the ratio of powder to water 1/10, that is, add 900ml of water, steam distill for 2 hours, and collect the distillate Add 2450ml of water to decoct the dregs of the medicine and the rest of the leaves and other nine flavors for two times, 1 hour each time, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 200ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another grape pulp to make a syrup, combine it with the above-mentioned medicinal liquid and distillate, add sodium carboxymethylcellulose and sodium benzoate, adjust the total amount to 1000ml, stir well, filter, fill, and sterilize.
实施例4Example 4
大青叶450g、板蓝根270g、金银花270g、连翘270g、栀子270g、牡丹皮270g、黄芩270g、淡竹叶180g、地龙180g、重楼135g、柴胡270g、白薇180g、蔗糖800g、羧甲基纤维钠8g及苯甲酸钠3gDaqingye 450g, Banlangen 270g, Honeysuckle 270g, Forsythia 270g, Gardenia 270g, Moutan bark 270g, Scutellaria baicalensis 270g, Bamboo leaves 180g, Dilong 180g, Chonglou 135g, Bupleurum 270g, Baiwei 180g, sucrose 800g, carboxylate Sodium methylcellulose 8g and sodium benzoate 3g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即加水8100ml,水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水22050ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至600ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取蔗糖800g制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠、苯甲酸钠,调整总量1000剂,搅匀,滤过,灌装,灭菌,即得。For the above twelve flavors, crush Moutan Cortex, Bupleurum and Forsythia medicinal materials until they all pass 45 mesh, but not 30 mesh, add water according to the ratio of medicine powder to water 1/10, that is, add 8100ml of water, steam distill for 2 hours, and collect the distillate Add 22050ml of water to decoct medicinal residues and other nine flavors such as green leaves twice, each time for 1 hour, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 600ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another 800g of sucrose to make syrup, combine with the above liquid medicine and distillate, add sodium carboxymethyl cellulose and sodium benzoate, adjust the total amount to 1000 doses, stir well, filter, fill, and sterilize to get ready.
实施例5Example 5
大青叶50g、板蓝根270g、金银花30g、牡丹皮270g、连翘270g、柴胡30g、栀子30g、黄芩30g、淡竹叶180g、地龙20g、重楼135g、白薇180g、蔗糖600g、羧甲基纤维钠8g及苯甲酸钠1.5gDaqingye 50g, Banlangen 270g, Honeysuckle 30g, Moutan bark 270g, Forsythia 270g, Bupleurum 30g, Gardenia 30g, Scutellaria baicalensis 30g, Bamboo leaf 180g, Dilong 20g, Chonglou 135g, Baiwei 180g, sucrose 600g, carboxylate Sodium methylcellulose 8g and sodium benzoate 1.5g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即加水5700ml,水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水9250ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量70%,静置。取上清液回收乙醇,浓缩至298ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取蔗糖600g制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠、苯甲酸钠,调整总量至1000ml,搅匀,滤过,灌装,灭菌,即得。For the above twelve flavors, crush Moutan Cortex, Bupleurum and Forsythia medicinal materials until they all pass 45 mesh, but not 30 mesh, add water according to the ratio of powder to water 1/10, that is, add 5700ml of water, steam distill for 2 hours, and collect the distillate add water 9250ml and decoct twice for 1 hour each time, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 298ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another 600g of sucrose to make a syrup, combine with the above liquid medicine and distillate, add sodium carboxymethylcellulose and sodium benzoate, adjust the total amount to 1000ml, stir well, filter, fill, and sterilize to get ready.
实施例6大青叶450g、板蓝根30g、金银花270g、牡丹皮30g、连翘30g、柴胡270g、栀子270g、黄芩270g、淡竹叶20g、地龙180g、重楼15g、白薇20g、阿斯巴甜400g、羧甲基纤维钠8g及苯甲酸钠1.86gExample 6 Folium Folium 450g, Radix Isatidis 30g, Honeysuckle 270g, Cortex Moutan 30g, Forsythia 30g, Bupleurum 270g, Gardenia 270g, Scutellaria baicalensis 270g, Danzhuye 20g, Dilong 180g, Chonglou 15g, Baiwei 20g, A Spartame 400g, sodium carboxymethylcellulose 8g and sodium benzoate 1.86g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率l/10加水,即加水3300ml,水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水15250ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量70%,静置。取上清液回收乙醇,浓缩至369ml,加水搅匀,静置,取上清液,滤过,滤液浓缩至适量。另取蔗糖600g制成糖浆,与上述药液及蒸馏液合并,再加入羧甲基纤维钠、苯甲酸钠,调整总量至1000剂,搅匀,滤过,灌装,灭菌,即得。For the above twelve flavors, crush Moutan Cortex, Bupleurum, and Forsythia until all of them pass through 45 meshes, but not 30 meshes. Add water according to the ratio of medicine powder to water 1/10, that is, add 3300ml of water, steam distill for 2 hours, and collect the distillate Add 15250ml of water to decoct medicinal residues and other nine flavors such as green leaves twice, each time for 1 hour, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 369ml, add water, stir well, let stand, take the supernatant, filter, and concentrate the filtrate to an appropriate amount. Take another 600g of sucrose to make syrup, combine with the above liquid medicine and distillate, then add sodium carboxymethylcellulose and sodium benzoate, adjust the total amount to 1000 doses, stir well, filter, fill, and sterilize to get ready.
实施例7膜剂Embodiment 7 film dosage
大青叶150g、板蓝根90g、金银花90g、栀子90g、牡丹皮90g、柴胡90g、连翘90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、白薇60g、成膜材料羧甲基纤维钠溶液(1∶10)800g及丙二醇30gDaqingye 150g, Banlangen 90g, Honeysuckle 90g, Gardenia 90g, Moutan bark 90g, Bupleurum 90g, Forsythia 90g, Scutellaria baicalensis 90g, Bamboo leaf 60g, Dilong 60g, Chonglou 45g, Baiwei 60g, film-forming material carboxylate Sodium methylcellulose solution (1:10) 800g and propylene glycol 30g
以上十二味,将牡丹皮、柴胡、连翘药材粉碎至全部通过45目,但不能过30目,按药粉与水比率1/10加水,即加水2700ml,用水蒸汽蒸馏2h,收集蒸馏液;药渣与其余青叶等九味加水7350ml煎煮二次,每次1小时,合并煎液,滤过,滤液浓缩至适量,加乙醇使含醇量为70%,静置。取上清液回收乙醇,浓缩至200ml,加水搅匀,静置,取上清液,浓缩至适量。另取羧甲基纤维钠溶液,与上述药液及蒸馏液合并,加入丙二醇研匀,放置除去气泡,涂布于平板玻璃上制膜,干燥,脱膜剪成适当大小,封装与包装材料中,即得膜剂。For the above twelve flavors, crush Moutan Cortex, Bupleurum and Forsythia medicinal materials until they all pass 45 mesh, but not 30 mesh, add water according to the ratio of medicine powder to water 1/10, that is, add 2700ml of water, steam distill for 2 hours, and collect the distillate Add 7350ml of water to decoct the dregs of the medicinal herbs and other nine flavors such as green leaves for two times, each time for 1 hour, combine the decoction, filter, concentrate the filtrate to an appropriate amount, add ethanol to make the alcohol content 70%, and let it stand. Take the supernatant to recover ethanol, concentrate to 200ml, add water, stir well, let stand, take the supernatant, concentrate to an appropriate amount. Separately take sodium carboxymethyl cellulose solution, combine it with the above liquid medicine and distillate, add propylene glycol to grind it evenly, place it to remove air bubbles, apply it on flat glass to form a film, dry it, remove the film and cut it into an appropriate size, and pack it in the packaging material , to obtain the film agent.
实施例8颗粒剂Example 8 Granules
大青叶150g、板蓝根90g、金银花90g、栀子90g、牡丹皮90g、柴胡90g、连翘90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、白薇60g、蔗糖1000gDaqingye 150g, Banlangen 90g, Honeysuckle 90g, Gardenia 90g, Moutan bark 90g, Bupleurum 90g, Forsythia 90g, Scutellaria baicalensis 90g, Bamboo leaf 60g, Dilong 60g, Chonglou 45g, Baiwei 60g, sucrose 1000g
按实施例1,将所得药材浓缩液及蒸馏液合并,加入蔗糖,按照颗粒剂制法即可制得颗粒剂。According to Example 1, the obtained medicinal material concentrate and distillate are combined, sucrose is added, and granules can be prepared according to the granule preparation method.
实施例9片剂Example 9 tablet
大青叶150g、板蓝根90g、金银花90g、栀子90g、牡丹皮90g、柴胡90g、连翘90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、白薇60g、羧甲基淀粉钠30g、糊精30g、硬脂酸镁10gDaqingye 150g, Banlangen 90g, Honeysuckle 90g, Gardenia 90g, Moutan bark 90g, Bupleurum 90g, Forsythia 90g, Scutellaria baicalensis 90g, Bamboo leaves 60g, Dilong 60g, Chonglou 45g, Baiwei 60g, carboxymethyl starch Sodium 30g, dextrin 30g, magnesium stearate 10g
按实施例1,将所得药材浓缩液及蒸馏液合并,喷雾干燥,粉碎,加入辅料,压片成型,即得片剂。According to Example 1, the obtained medicinal material concentrate and distillate were combined, spray-dried, pulverized, added with auxiliary materials, and compressed into tablets to obtain tablets.
实施例10胶囊剂Embodiment 10 capsules
大青叶150g、板蓝根90g、金银花90g、栀子90g、牡丹皮90g、柴胡90g、连翘90g、黄芩90g、淡竹叶60g、地龙60g、重楼45g、白薇60g、淀粉30g、滑石10gDaqingye 150g, Banlangen 90g, Honeysuckle 90g, Gardenia 90g, Moutan bark 90g, Bupleurum 90g, Forsythia 90g, Scutellaria baicalensis 90g, Bamboo leaves 60g, Dilong 60g, Chonglou 45g, Baiwei 60g, Starch 30g, Talc 10g
按实施例1,将所得药材浓缩液及蒸馏液合并,喷雾干燥,粉碎,加入辅料,装入胶囊,即得胶囊剂。According to Example 1, the obtained medicinal material concentrate and distillate were combined, spray-dried, pulverized, added with auxiliary materials, and packed into capsules to obtain capsules.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100032713A CN100362983C (en) | 2005-11-10 | 2005-11-10 | A traditional Chinese medicine preparation for reducing fever in children and its preparation method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100032713A CN100362983C (en) | 2005-11-10 | 2005-11-10 | A traditional Chinese medicine preparation for reducing fever in children and its preparation method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1785371A CN1785371A (en) | 2006-06-14 |
| CN100362983C true CN100362983C (en) | 2008-01-23 |
Family
ID=36783039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100032713A Expired - Lifetime CN100362983C (en) | 2005-11-10 | 2005-11-10 | A traditional Chinese medicine preparation for reducing fever in children and its preparation method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100362983C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101279056B (en) * | 2008-05-28 | 2012-03-07 | 山东沃华医药科技股份有限公司 | Children's antipyretic granule |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102145134B (en) * | 2007-03-23 | 2012-10-31 | 北京亚东生物制药有限公司 | Detection methods of pharmaceutical composition for treatment of wind-heat cold of children |
| CN101822779B (en) * | 2010-05-14 | 2012-05-02 | 江西中成中药原料有限公司 | Jinye Qingwen powder and preparation method thereof |
| CN104547680B (en) * | 2014-12-25 | 2018-03-09 | 北京亚东生物制药有限公司 | A kind of plastics for being used for children's antipyretic and paediatric acute tonsillitis |
| CN104688882A (en) * | 2015-03-21 | 2015-06-10 | 王雪雁 | TCM (Traditional Chinese Medicine) composition for treating fever in children |
| CN106267046A (en) * | 2015-05-15 | 2017-01-04 | 王世祥 | The Chinese medicine formula that a kind of juvenile for the treatment of brings down a fever |
| CN105327179A (en) * | 2015-11-30 | 2016-02-17 | 四川美大康药业股份有限公司 | Preparation method of infantile febrifugal oral liquid preparation |
| CN105963558A (en) * | 2016-06-12 | 2016-09-28 | 佛山市腾瑞医药科技有限公司 | Plant extract for treating fever of children and application thereof |
| CN106265912A (en) * | 2016-08-22 | 2017-01-04 | 齐齐哈尔医学院 | A kind of Chinese medicine compound cream treating fever of children and preparation method thereof |
| CN115531492A (en) * | 2022-09-21 | 2022-12-30 | 青岛权道管理咨询有限公司 | Preparation method of heat dissipation gel |
| CN117660111B (en) * | 2024-01-31 | 2024-04-16 | 山东义才和锐生物技术有限公司 | Extraction method of camellia essential oil |
-
2005
- 2005-11-10 CN CNB2005100032713A patent/CN100362983C/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| 卫生部颁药品标准中药成方制剂. 卫生部,19,卫生部. 1992 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101279056B (en) * | 2008-05-28 | 2012-03-07 | 山东沃华医药科技股份有限公司 | Children's antipyretic granule |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1785371A (en) | 2006-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2450046B1 (en) | A medicinal composition for the treatment of bronchitis and preparation thereof | |
| CN102438630B (en) | Pharmaceutical composition, preparation method and application for treating depression | |
| CN102430090A (en) | Traditional Tibetan medicine Ruyizhenbao composite preparation and preparation method thereof | |
| CN1785371A (en) | Chinese medicinal preparation for abating child fever and its preparation method | |
| CN1698750A (en) | Pharyngitis treating Chinese medicine | |
| CN104510853B (en) | A kind of Chinese medicinal effective-part composition for the treatment of dysmenorrhes and uses thereof | |
| CN118576681B (en) | Liver protecting composition and preparation method thereof | |
| CN102526536B (en) | An'erning medicinal composition buccal tablet and preparation method and application thereof | |
| CN101690755A (en) | Antivirus extract and preparation method thereof | |
| CN102048967A (en) | Inflammation-diminishing and heat-clearing composition and preparation method thereof | |
| CN1733182A (en) | Medicinal composition for treating exogenous fever and preparation method thereof | |
| CN106138254A (en) | A kind of preparation method and applications of antiphlogistic bezoar buccal tablet | |
| CN100353968C (en) | Chinese medicine preparation for nourishing blood and tranquilizing mind and its preparation process | |
| CN1970032B (en) | Chinese medicine containing honeysuckle flower and weeping forsythia for treating cold | |
| CN103040939B (en) | Traditional Chinese medicine composition for treating cold, as well as preparation method and application thereof | |
| CN1292779C (en) | Chinese traditional medicine preparation for treating paediatric acute tonsillitis | |
| CN110448622B (en) | Medicine for treating heat type cold and preparation method and application thereof | |
| CN100563634C (en) | A kind of Herba Sidae Rhombifoliae soup drop pill | |
| CN1943734B (en) | A Chinese traditional medicine for clearing away heat and toxic material | |
| CN101732644A (en) | External preparation for treating gynaecopathia and dermatosis and preparation method thereof | |
| CN115645490B (en) | Tablet for pharyngitis and preparation method thereof | |
| CN111110756A (en) | Traditional Chinese medicine composition for treating infantile heat asthma and preparation method thereof | |
| CN1823982A (en) | Chinese medicinal preparation for liver soothing and speen fortifying and its manufacturing method | |
| CN101176749A (en) | Chaihuang freeze-dried powder injection and preparation method thereof | |
| CN105327219A (en) | Traditional Chinese medicine composition for treating female pelvic inflammation and preparation method of traditional Chinese medicine composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CX01 | Expiry of patent term | ||
| CX01 | Expiry of patent term |
Granted publication date: 20080123 |

